MIRA Pharmaceuticals, Inc. (MIRA) News
Follow MIRA Pharmaceuticals, Inc. (MIRA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
MIRA - MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
MIRA - MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
REGULATION | Sep 17, 2026, 12:30 PM UTC
L
MIRA Pharmaceuticals reports positive 7-day toxicology results for MIRA-55
MIRA Pharmaceuticals said 7-day dose-range toxicology and toxicokinetic results for MIRA-55 support dose selection and a targeted Q1 2027 IND submission.
REGULATION | Sep 01, 2026, 12:13 PM UTC
L
MIRA Pharmaceuticals advances oral MIRA-55 toward IND
MIRA Pharmaceuticals said it is advancing non-opioid oral MIRA-55 for inflammatory pain toward an IND.
EQUITY | Sep 01, 2026, 12:00 PM UTC
L
MIRA - MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
MIRA - MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
EQUITY | Aug 06, 2026, 12:00 PM UTC
M
MIRA progresses MIRA-55 and SKNY-1
MIRA advances two pharmaceutical products
EQUITY | Jul 30, 2026, 12:01 PM UTC
L
Mira Pharmaceuticals Says SKNY-1 in Obesity, Addiction Shows 'Favorable' Bioavailability in Preclinical Studies
() -- Mira Pharmaceuticals (MIRA) said Monday that preclinical studies evaluating the oral formulation of SKNY-1 for obesity and addiction-related disorders showed "favorable" bioavailability along with reproducible syst
EQUITY | Jul 06, 2026, 01:44 PM UTC
M
MIRA Reports Preclinical Data
MIRA Pharmaceuticals reports new preclinical data demonstrating Mira-55's differentiated mechanism of action and anxiolytic activity relative to THC
EARNINGS | Jun 25, 2026, 12:15 PM UTC